Evidence map›Paper›PMID 27588755›Full record

ArticlePloS one2016

Comparative Analysis of Immune Repertoires between Bactrian Camel's Conventional and Heavy-Chain Antibodies.

Xinyang Li, Xiaobo Duan, Kai Yang, Wei Zhang, Changjiang Zhang, Longfei Fu, Zhe Ren, Changxi Wang, Jinghua Wu, Ruxue Lu and 8 more

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Distinct types of VHHs in Alpaca.Frontiers in immunology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Xinyang LiBGI-Shenzhen, Shenzhen 518083, China.
Xiaobo DuanGuangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering, School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
Kai YangBGI-Shenzhen, Shenzhen 518083, China.
Wei ZhangBGI-Shenzhen, Shenzhen 518083, China.
Changjiang ZhangGuangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering, School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
Longfei FuBGI-Shenzhen, Shenzhen 518083, China.
Zhe RenBGI-Shenzhen, Shenzhen 518083, China.
Changxi WangBGI-Shenzhen, Shenzhen 518083, China.
Jinghua WuBGI-Shenzhen, Shenzhen 518083, China.
Ruxue LuZhangye City Bureau of Animal Husbandry and Veterinary, Zhangye, Gansu, 734000, China.
Yanrui YeGuangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering, School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
Mengying HeGuangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering, School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
Chao NieBGI-Shenzhen, Shenzhen 518083, China.
Naibo YangBGI-Shenzhen, Shenzhen 518083, China.
Jian WangBGI-Shenzhen, Shenzhen 518083, China.
Huanming YangBGI-Shenzhen, Shenzhen 518083, China.
Xiao LiuBGI-Shenzhen, Shenzhen 518083, China.
Wen TanGuangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering, School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.ORCID http://orcid.org/0000-0003-2272-0861

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Compared to classical antibodies, camel heavy chain antibodies (HCAbs) are smaller in size due to lack of the light chain and the first constant domain of the heavy chain (CH1 region). The variable regions of HCAbs (VHHs) are more soluble and stable than that of conventional antibodies (VHs). Even with such simple structure, they are still functional in antigen binding. Although HCAbs have been extensively investigated over the past two decades, most efforts have been based upon low throughput sequence analysis, and there are only limited reports trying to analyze and describe the complete immune repertoire (IR) of camel HCAbs. Here we leveraged the high-throughput data generated by Next Generation Sequencing (NGS) of the variable domains of the antibody heavy chains from three Bactrian camels to conduct in-depth comparative analyses of the immunoglobulin repertoire. These include analyses of the complementary determining region 3 (CDR3) length and distribution, mutation rate, antibody characteristic amino acids, the distribution of the cysteine (Cys) codons, and the non-classical VHHs. We found that there is higher diversity in the CDR2 than in the other sub-regions, and there is a higher mutation rate in the VHHs than in the VHs (P < 0.05). In addition to substitutions at amino acid (AA) residue positions NO.49/50/52 between VH and VHH clones, we also observed other substitutions at the positions NO.40/54/57/96/101 that could lead to additional structural alterations. We also found that VH-derived VHH clones, referred to as non-classical VHH clones in this study, accounted for about 8% of all clones. Further, only 5%-10% clones had the Trp > Arg AA substitution at the first position of framework 4 for all types of clones. We present, for the first time, a relatively complete picture of the Bactrian camel antibody immune repertoire, including conventional antibody (Ab) and HCAbs, using PCR and in silico analysis based on high-throughput NGS data.

Indexed as

Genes, ImmunoglobulinAnimalsCamelusHigh-Throughput Nucleotide SequencingImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionImmunoglobulin Heavy ChainsImmunoglobulin Variable Region

Identifiers

PMID27588755
PMCPMC5010241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.